tradingkey.logo

碧迪医疗

BDX
查看详细走势图
200.220USD
-0.670-0.33%
交易中 美东报价延迟15分钟
57.14B总市值
34.32市盈率 TTM

碧迪医疗

200.220
-0.670-0.33%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-0.33%

5天

+3.23%

1月

+3.72%

6月

+16.27%

今年开始到现在

-11.75%

1年

-11.23%

查看详细走势图

TradingKey 碧迪医疗股票评分

单位: USD 更新时间: 2025-12-12

操作建议

碧迪医疗当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名3/208位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价203.75。中期看,股价处于平稳状态。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

碧迪医疗评分

相关信息

行业排名
3 / 208
全市场排名
47 / 4592
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 14 位分析师
买入
评级
203.751
目标均价
+7.52%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

碧迪医疗亮点

亮点风险
Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
利润高增长
公司净利润处于行业前列,最新年度总收入21.84B美元
高分红
公司属于高分红公司,最新股息支付率71.28%
稳定分红
公司5年内连续分红,最新股息支付率71.28%
估值低估
公司最新PE估值34.44,处于3年历史低位
机构加仓
最新机构持股268.89M股,环比增加0.03%
HACAX持仓
明星投资者HACAX持仓,最新持仓市值4.84K

碧迪医疗新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

碧迪医疗简介

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
公司代码BDX
公司碧迪医疗
CEOPolen (Thomas E)
网址https://www.bd.com/

常见问题

碧迪医疗(BDX)的当前股价是多少?

碧迪医疗(BDX)的当前股价是 200.220。

碧迪医疗的股票代码是什么?

碧迪医疗的股票代码是BDX。

碧迪医疗股票的52周最高点是多少?

碧迪医疗股票的52周最高点是251.985。

碧迪医疗股票的52周最低点是多少?

碧迪医疗股票的52周最低点是162.290。

碧迪医疗的市值是多少?

碧迪医疗的市值是57.14B。

碧迪医疗的净利润是多少?

碧迪医疗的净利润为1.68B。

现在碧迪医疗(BDX)的股票是买入、持有还是卖出?

根据分析师评级,碧迪医疗(BDX)的总体评级为买入,目标价格为203.751。

碧迪医疗(BDX)股票的每股收益(EPS TTM)是多少

碧迪医疗(BDX)股票的每股收益(EPS TTM)是5.834。
KeyAI